p.56 抽出テキスト

133.	 Akar JG, Kok LC, Haines DE, et al. Coexistence of type I atrial flutter and intra-atrial re-entrant tachycardia in patients with surgically corrected congenital heart disease. J Am Coll Cardiol. 2001;38:377–84. 134.	 Jaïs P, Shah DC, Haïssaguerre M, et al. Mapping and ablation of left atrial flutters. Circulation. 2000;101:2928–34. 135.	 Coffey JO, d’Avila A, Dukkipati S, et al. Catheter ablation of scar-related atypical atrial flutter. Europace. 2013;15:414–9. 136.	 Triedman JK, Bergau DM, Saul JP, et al. Efficacy of radiofrequency ablation for control of intraatrial reentrant tachycardia in patients with congenital heart disease. J Am Coll Cardiol. 1997;30:1032–8. 137.	 Nakagawa H, Shah N, Matsudaira K, et al. Characterization of reentrant circuit in macroreentrant right atrial tachycardia after surgical repair of congenital heart disease: isolated channels between scars allow “focal” ablation. Circulation. 2001;103:699–709. 138.	 Chan DP, Van Hare GF, Mackall JA, et al. Importance of atrial flutter isthmus in postoperative intra-atrial reentrant tachycardia. Circulation. 2000;102:1283–9. 139.	 Stevenson IH, Kistler PM, Spence SJ, et al. Scar-related right atrial macroreentrant tachycardia in patients without prior atrial surgery: electroanatomic characterization and ablation outcome. Heart Rhythm. 2005;2:594–601. 140.	 Baker BM, Lindsay BD, Bromberg BI, et al. Catheter ablation of clinical intraatrial reentrant tachycardias resulting from previous atrial surgery: localizing and transecting the critical isthmus. J Am Coll Cardiol. 1996;28:411–7. 141.	 Haines DE, Beheiry S, Akar JG, et al. Heart Rythm Society expert consensus statement on electrophysiology laboratory standards: process, protocols, equipment, personnel, and safety. Heart Rhythm. 2014;11:e9–51. 142.	 Knight BP, Zivin A, Souza J, et al. A technique for the rapid diagnosis of atrial tachycardia in the electrophysiology laboratory. J Am Coll Cardiol. 1999;33:775–81. 143.	 Horowitz LN, Kay HR, Kutalek SP, et al. Risks and complications of clinical cardiac electrophysiologic studies: a prospective analysis of 1,000 consecutive patients. J Am Coll Cardiol. 1987;9:1261–8. 144.	 Asirvatham S, Narayan O. Advanced catheter mapping and navigation system. In: Huang SW, Wood M, editors. Catheter Ablation of Cardiac Arrhythmias. Philadelphia, PA: Saunders/Elsevier, 2006:135–61. 145.	 Sporton SC, Earley MJ, Nathan AW, et al. Electroanatomic versus fluoroscopic mapping for catheter ablation procedures: a prospective randomized study. J Cardiovasc Electrophysiol. 2004;15:310–5. 146.	 Kopelman HA, Prater SP, Tondato F, et al. Slow pathway catheter ablation of atrioventricular nodal re-entrant tachycardia guided by electroanatomical mapping: a randomized comparison to the conventional approach. Europace. 2003;5:171–4. 147.	 Hindricks G, Willems S, Kautzner J, et al. Effect of electroanatomically guided versus conventional catheter ablation of typical atrial flutter on the fluoroscopy time and resource use: a prospective randomized multicenter study. J Cardiovasc Electrophysiol. 2009;20:734–40. 148.	 Mah DY, Miyake CY, Sherwin ED, et al. The use of an integrated electroanatomic mapping system and intracardiac echocardiography to reduce radiation exposure in children and young adults undergoing ablation of supraventricular tachycardia. Europace. 2014;16:277–83. 149.	 Alvarez M, Tercedor L, Almansa I, et al. Safety and feasibility of catheter ablation for atrioventricular nodal re-entrant tachycardia without fluoroscopic guidance. Heart Rhythm. 2009;6:1714–20. 150.	 Casella M, Pelargonio G, Dello RA, et al. “Near-zero” fluoroscopic exposure in supraventricular arrhythmia ablation using the EnSite NavXTM mapping system: personal experience and review of the literature. J Interv Card Electrophysiol. 2011;31:109–18. 151.	 Razminia M, Manankil MF, Eryazici PLS, et al. Nonfluoroscopic catheter ablation of cardiac arrhythmias in adults: feasibility, safety, and efficacy. J Cardiovasc Electrophysiol. 2012;23:1078–86. 152.	 Earley MJ, Showkathali R, Alzetani M, et al. Radiofrequency ablation of arrhythmias guided by non-fluoroscopic catheter location: a prospective randomized trial. Eur Heart J. 2006;27:1223–9. 153.	 Xu D, Yang B, Shan Q, et al. Initial clinical experience of remote magnetic navigation system for catheter mapping and ablation of supraventricular tachycardias. J Interv Card Electrophysiol. 2009;25:171–4. 154.	 Sommer P, Wojdyla-Hordynska A, Rolf S, et al. Initial experience in ablation of typical atrial flutter using a novel three-dimensional catheter tracking system. Europace. 2013;15:578–81. 155.	 Cummings JE, Pacifico A, Drago JL, et al. Alternative energy

sources for the ablation of arrhythmias. Pacing Clin Electrophysiol. 2005;28:434–43. 156.	 Hanninen M, Yeung-Lai-Wah N, Massel D, et al. Cryoablation versus RF

ablation for AVNRT: a meta-analysis and systematic review. J Cardiovasc Electrophysiol. 2013;24:1354–60. 157.	 Friedman PL, Dubuc M, Green MS, et al. Catheter cryoablation of supraventricular tachycardia: results of the multicenter prospective “frosty” trial. Heart Rhythm. 2004;1:129–38. 158.	 Rodriguez-Entem FJ, Expósito V, Gonzalez-Enriquez S, et al. Cryoablation versus radiofrequency ablation for the treatment of atrioventricular nodal reentrant tachycardia: results of a prospective randomized study. J Interv Card Electrophysiol. 2013;36:41–5. 159.	 Eckhardt LLL, Leal M, Hollis Z, et al. Cryoablation for AVNRT: importance of ablation endpoint criteria. J Cardiovasc Electrophysiol. 2012;23:729–34. 160.	 Olshansky B, Sullivan RM. Inappropriate sinus tachycardia. J Am Coll Cardiol. 2013;61:793–801. 161.	 Marcus B, Gillette PC, Garson A. Intrinsic heart rate in children and young adults: an index of sinus node function isolated from autonomic control. Am Heart J. 1990;119:911–6. 162.	 Jose AD, Collison D. The normal range and determinants of the intrinsic heart rate in man. Cardiovasc Res. 1970;4:160–7. 163.	 Alboni P, Malcarne C, Pedroni P, et al. Electrophysiology of normal sinus node with and without autonomic blockade. Circulation. 1982;65:1236–42. 164.	 Winum P-F, Cayla G, Rubini M, et al. A case of cardiomyopathy induced by inappropriate sinus tachycardia and cured by ivabradine. Pacing Clin Electrophysiol. 2009;32:942–4. 165.	 Romeo E, Grimaldi N, Sarubbi B, et al. A pediatric case of cardiomyopathy induced by inappropriate sinus tachycardia: efficacy of ivabradine. Pediatr Cardiol. 2011;32:842–5. 166.	 Fox K, Ford I, Steg PG, et al. Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial. Lancet. 2008;372:807–16. 167.	 Swedberg K, Komajda M, Böhm M, et al. Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study. Lancet. 2010;376:875–85. 168.	 Cappato R, Castelvecchio S, Ricci C, et al. Clinical efficacy of ­ivabradine in patients with inappropriate sinus tachycardia: a prospective, randomized, placebo-controlled, double-blind, crossover evaluation. J Am Coll Cardiol. 2012;60:1323–9. 169.	 Benezet-Mazuecos J, Rubio JM, Farré J, et al. Long-term outcomes of ivabradine in inappropriate sinus tachycardia patients: appropriate efficacy or inappropriate patients. Pacing Clin Electrophysiol. 2013;36:830–6. 170.	 Ptaszynski P, Kaczmarek K, Ruta J, et al. Metoprolol succinate vs. ivabradine in the treatment of inappropriate sinus tachycardia in patients unresponsive to previous pharmacological therapy. Europace. 2013;15:116–21. 171.	 Ptaszynski P, Kaczmarek K, Ruta J, et al. Ivabradine in the treatment of inappropriate sinus tachycardia in patients after successful radiofrequency catheter ablation of atrioventricular node slow pathway. Pacing Clin Electrophysiol. 2013;36:42–9. 172.	 Ptaszynski P, Kaczmarek K, Ruta J, et al. Ivabradine in combination with metoprolol succinate in the treatment of inappropriate sinus tachycardia. J Cardiovasc Pharmacol Ther. 2013;18:338–44. 173.	 Calò L, Rebecchi M, Sette A, et al. Efficacy of ivabradine administration in patients affected by inappropriate sinus tachycardia. Heart Rhythm. 2010;7:1318–23. 174.	 Kaplinsky E, Comes FP, Urondo LSV, et al. Efficacy of ivabradine in four patients with inappropriate sinus tachycardia: a three month-long experience based on electrocardiographic, Holter monitoring, exercise tolerance and quality of life assessments. Cardiol J. 2010;17:166–71. 175.	 Rakovec P. Treatment of inappropriate sinus tachycardia with ivabradine. Wien Klin Wochenschr. 2009;121:715–8. 176.	 Zellerhoff S, Hinterseer M, Felix Krull B, et al. Ivabradine in patients with inappropriate sinus tachycardia. Naunyn Schmiedebergs Arch Pharmacol. 2010;382:483–6. 177.	 Man KC, Knight B, Tse HF, et al. Radiofrequency catheter ablation of inappropriate sinus tachycardia guided by activation mapping. J Am Coll Cardiol. 2000;35:451–7. 178.	 Lin D, Garcia F, Jacobson J, et al. Use of noncontact mapping and saline-cooled ablation catheter for sinus node modification in medically refractory inappropriate sinus tachycardia. Pacing Clin Electrophysiol. 2007;30:236–42. 179.	 Lee RJ, Kalman JM, Fitzpatrick AP, et al. Radiofrequency catheter

modification of the sinus node for “inappropriate” sinus tachycardia. Circulation. 1995;92:2919–28.

Downloaded from http://ahajournals.org by on October 7, 2026